Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Public ClinicalTrials.gov record NCT00099242. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease.
Study identification
- NCT ID
- NCT00099242
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,040 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Jan 2006 (Actual)
- Last update posted
- Oct 13, 2017
2003 – 2006
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Orange | California | 92868-3298 | — |
| Not listed | San Francisco | California | 94109 | — |
| Not listed | Boca Raton | Florida | 33486 | — |
| Not listed | Fort Lauderdale | Florida | 33321 | — |
| Not listed | Miami | Florida | 33137 | — |
| Not listed | Miami Beach | Florida | 33154 | — |
| Not listed | Port Charlotte | Florida | 33952 | — |
| Not listed | West Palm Beach | Florida | 33407 | — |
| Not listed | Snellville | Georgia | 30078 | — |
| Not listed | St Louis | Missouri | 63104 | — |
| Not listed | Omaha | Nebraska | 68131 | — |
| Not listed | Long Branch | New Jersey | 07740 | — |
| Not listed | Toms River | New Jersey | 08755 | — |
| Not listed | Whiting | New Jersey | 08759 | — |
| Not listed | Columbus | Ohio | 43215 | — |
| Not listed | Dayton | Ohio | 45415 | — |
| Not listed | Oklahoma City | Oklahoma | 73118 | — |
| Not listed | Greensburg | Pennsylvania | 15601 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Austin | Texas | 78756 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00099242, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2017 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00099242 live on ClinicalTrials.gov.